Please try another search
Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
Name | Age | Since | Title |
---|---|---|---|
Richard S. Greenberg | 72 | 2017 | Founder, CEO, Executive VP & Chairman |
Lindy Lou Snider | 60 | 2018 | Independent Director |
Joseph F. Aceto | - | 2018 | Advisor |
Benedikt Schoser | - | - | Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review